DNA-Loaded Cationic Liposomes Efficiently Function as a Vaccine against Malarial Proteins
Author(s) -
Wesley Luzetti Fotoran,
Rachele Santangelo,
Beatriz Nogueira Messias de Miranda,
Darrell J. Irvine,
Gerhard Wunderlich
Publication year - 2017
Publication title -
molecular therapy — methods and clinical development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.285
H-Index - 32
ISSN - 2329-0501
DOI - 10.1016/j.omtm.2017.08.004
Subject(s) - dna vaccination , plasmodium falciparum , antigen , merozoite surface protein , virology , circumsporozoite protein , naked dna , recombinant dna , rhoptry , liposome , cationic liposome , biology , malaria vaccine , transfection , antibody , plasmid , chinese hamster ovary cell , immune system , dna , malaria , immunology , immunization , cell culture , biochemistry , gene , genetics , apicomplexa
The delivery of antigens as DNA vaccines is an efficient alternative to induce immune responses against antigens, which are difficult to produce in recombinant form. However, the delivery of naked DNA is ineffective or relies on sophisticated ballistic devices. Here, we show a combination of liposome application and naked DNA vaccine that successfully overcomes these problems. Upon entrapment of plasmids encoding different antigens in cationic particles, transfection efficiencies similar to commercial kits were achieved in in vitro cell cultures. The liposome-based approach provided strong humoral responses against three malarial antigens, namely the Circumsporozoite protein and the C terminus of merozoite surface protein 1 from Plasmodium vivax (titers 10 4 or 10 3 -10 4 , respectively) and P. falciparum Rhoptry antigen 5 from Plasmodium falciparum (titers 10 3 -10 4 ). When employed in P. falciparum growth-inhibition assays, antibodies demonstrated consistent reinvasion-blocking activities that were dose dependent. Liposome-formulated DNA vaccines may prove useful when targets cannot be produced as recombinant proteins and when conformation-dependent and highly specific antibodies are mandatory.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom